Renal Safety of Liposomal Amphotericin B After Liver Transplantation

Prog Transplant. 2020 Jun;30(2):179-181. doi: 10.1177/1526924820913504. Epub 2020 Apr 10.

Authors

Alessandro Perrella¹, Ciro Esposito², Antonio Giuliani³, Carla Migliaccio³, Giorgia Granato², Walter Santaniello³, Giovanni Vennarecci³

Affiliations

¹ VII Department of Infectious Disease and Immunology, AORN Monaldi-Cotugno-CTO, Naples, Italy.
² Liver Intensive Care Unit, AORN A. Cardarelli, Naples, Italy.
³ Laproscopic, Hepatic, and Liver Transplant Unit, AORN A. Cardarelli, Naples, Italy.

PMID: 32274972
DOI: 10.1177/1526924820913504

No abstract available

Keywords: fungal infection; liver transplant; posttransplant infection; renal function.

MeSH terms

Amphotericin B / therapeutic use*
Antifungal Agents / therapeutic use*
Caspofungin / therapeutic use*
Fungemia / drug therapy*
Humans
Liver Transplantation*
Patient Safety
Retrospective Studies

Substances

Antifungal Agents
liposomal amphotericin B
Amphotericin B
Caspofungin